Syncromune™ — Synchronizing the Power of Immunotherapy®

Synchronizing

THE POWER OF

Immunotherapy

bringing hope to metastatic cancer patients

Syncromune^® is a clinical-stage biopharmaceutical company focused on developing SYNC-T^™, a disruptive platform technology optimized to attack metastatic solid tumors.

Disclaimers: The content on this website is intended for US healthcare professionals only. The compounds and their uses mentioned on this website are investigational and have not been determined safe and effective by the US Food and Drug Administration.

Synchronizing

THE POWER OF

Syncromune® is a clinical-stage biopharmaceutical company focused on developing SYNC-T™, a disruptive platform technology optimized to attack metastatic solid tumors.

Syncromune^® is a clinical-stage biopharmaceutical company focused on developing SYNC-T^™, a disruptive platform technology optimized to attack metastatic solid tumors.